DRTS
Alpha Tau Medical Ltd.
NASDAQ · ILHealthcareBiotechnology
$13.47-0.59%
Price as of Jul 20, 2026
DRTS financials
Alpha Tau Medical Ltd. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of revenue | $1.2M | $1.1M | $1.1M | $979.0K |
| Gross profit | -$1.2M | -$1.1M | -$1.1M | -$979.0K |
| Operating expenses | $41.1M | $34.9M | $34.6M | $32.1M |
| Operating income | -$42.3M | -$36.0M | $35.7M | -$32.1M |
| Net income | -$42.6M | -$31.8M | -$29.2M | -$33.8M |
| EBITDA | -$41.1M | -$30.3M | -$28.0M | -$32.7M |
| Basic EPS | $-0.53 | $-0.45 | $-0.42 | $-0.53 |
| Diluted EPS | $-0.53 | $-0.45 | $-0.42 | $-0.53 |
| Balance sheet | ||||
| Cash & equivalents | $16.0M | $13.7M | $12.7M | $5.8M |
| Total assets | $106.6M | $86.2M | $107.4M | $120.1M |
| Total liabilities | $29.5M | $23.5M | $22.9M | $14.5M |
| Stockholders’ equity | $77.1M | $62.7M | $84.5M | $105.7M |
| Total debt | $13.7M | $12.5M | $13.3M | $5.2M |
| Net debt | -$2.3M | -$1.2M | $619.0K | -$643.0K |
| Cash flow | ||||
| Operating cash flow | -$26.7M | -$19.8M | -$18.0M | -$23.9M |
| Capital expenditure | -$6.1M | -$2.2M | -$6.4M | -$904.0K |
| Free cash flow | -$32.8M | -$22.0M | -$24.4M | -$24.8M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |